Utilisation of further healthcare resources of patients with Alzheimer's during the intervention period of intense occupational therapy compared with a single session control intervention (German completers of the Community Occupational Therapy in Dementia Programme and control group)
| Healthcare resources | Community Occupational Therapy in Dementia Programme (n=54) | Control (n=50) | ||||
| Mean (SD) | Range | Skewness | Mean (SD) | Range | Skewness | |
| Medical consultations per week | ||||||
| General practitioner | 0.28 (0.40) | 0–2.33 | 3.211 | 0.18 (0.17) | 0–0.67 | 0.828 |
| Neurologist or psychiatrist | 0.04 (0.09) | 0–0.33 | 2.092 | 0.03 (0.09) | 0–0.50 | 3.508 |
| Other medical expert | 0.14 (0.26) | 0–1.33 | 2.778 | 0.15 (0.24) | 0–1.00 | 1.825 |
| Hours for therapy per week | ||||||
| Individual therapy | 0.14 (0.32) | 0–1.00 | 2.029 | 0.11 (0.29) | 0–1.00 | 2.597 |
| Group therapy | 1.05 (2.92) | 0–14.00 | 3.064 | 0.88 (3.32) | 0–16.00 | 4.163 |
| Hours for nursing or domestic home care per week | 1.33 (3.23) | 0–15.08 | 3.074 | 1.87 (5.32) | 0–25.54 | 3.173 |
| No of technical aids provided at home | 0.15 (0.49) | 0–3.00 | 4.306 | 0.06 (0.24) | 0–3.00 | 3.821 |
| Comorbidity (Cumulative Illness Rating Scale24) | 3.15 (3.20) | 0–13 | 1.101 | 2.42 (2.60) | 0–11 | 1.374 |
| No of patients with acetylcholinesterase-inhibitor medication | ||||||
| De-novo treatment or increased dose | 4 (7%) | 3 (6%) | ||||
| Decreased dose or medication ceased | 2 (4%) | 1 (2%) | ||||
| Constant level | 34 (63%) | 26 (52%) | ||||
| No acetylcholinesterase-inhibitors | 14 (26%) | 20 (40%) | ||||